Skip to main content

Table 3 Multiplicative and additive interactiona between diabetes mellitus and ever glucocorticoid use

From: The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study

OutcomeMultiplicative interactionAdditive interaction
Hazard ratio (95% confidence interval)RERI (95% confidence interval)RAE (95% confidence interval)
All-cause mortality
 Unadjusted0.69 (0.51 to 0.91)0.94 (−0.29 to 2.16)1.27 (0.95 to 1.70)
All-cause mortality
 Adjustedb0.86 (0.64 to 1.15)0.41 (−0.36 to 1.18)1.22 (0.86 to 1.72)
CV mortality
 Unadjusted0.70 (0.44 to 1.11)0.40 (−1.19 to 2.00)1.17 (0.64 to 2.14)
CV mortality
 Adjustedb0.93 (0.60 to 1.48)0.11 (−0.75 to 0.96)1.11 (0.48 to 2.57)
  1. a On the multiplicative scale significant interaction is different than 1, on the additive scale significant interaction for the RERI is different than 0 and for the RAE is different than 1
  2. bAdjusted for age, gender, Charlson comorbidity index, baseline BMI, baseline smoking status, DMARDs, prior GC, prior macrovascular disease and NSAIDs